A crisis of vaccine inequity

Translate to Spanish or other 102 languages!

Health leaders have called for urgent global cooperation on COVID-19 vaccine supply and access. World Health Organization Image

Mega Doctor News

- Advertisement -

World Health Organization – Health leaders have called for urgent global cooperation on COVID-19 vaccine supply and access, particularly in Africa where only 2% of total doses worldwide have been administered.

The longer vaccine inequity persists, the more the virus will keep circulating and changing, the longer the social and economic disruption will continue, and the higher the chances that more variants will emerge that render vaccines less effective.” 

Dr Tedros Adhanom Ghebreyesus, Director-General, WHO

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?

STHS Earns Another 5-Star Healthgrades Distinction for Hip Fracture Care

For the sixth consecutive year, STHS McAllen and STHS Edinburg have earned a Five-Star Rating for Hip Fracture Treatment from Healthgrades, one of the nation's leading resources for evaluating hospital performance.

Raising Awareness, One Step at a Time: STHS Edinburg Hosts Sept. 23 Walkathon

To raise awareness about the condition and encourage residents to take proactive steps toward better vascular health, the STHS Limb Salvage & Amputation Prevention Program will host the Step Out PAD Walkathon on Wednesday, September 23, 2026, at STHS Edinburg, from 6:30 to 7:30 p.m.

FDA Launches Expedited IND Pilot to Speed Up Clinical Trials

The U.S. Food and Drug Administration today announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American leadership in global medical innovation is a core priority for the Trump Administration.
- Advertisement -